|
|
|
|
|
|
|
|
| FAPI 04 without DOTA |
| FAPI 46 without DOTA |
| OncoFAP |
| Suc-OncoFAP |
| Boc-FAPI 04-COOH |
| Boc-FAPI 46-COOH |
| FAPI 02 without DOTA |
| Suc-FAPI 04 without DOTA |
| Suc-FAPI 46 without DOTA |
| H-PEG2乙酸-FAPI 04 without DOTA |
| H-PEG2丙酸-FAPI 04 without DOTA |
| H-Gly-OncoFAP |
| H-PEG2(乙酸)-FAPI 02 |
| H-PEG4(丙酸)-FAPI 04 |
| H-PEG4(丙酸)-OncoFAP |
| H-PEG6(丙酸)-OncoFAP |
| H-PEG8(丙酸)-OncoFAP |
| DOTA-方酸-PEG4(丙酸)-OncoFAP |
| 68Ga-DOTA-方酸-PEG4(丙酸)-OncoFAP |
| 177Lu-DOTA-方酸-PEG4(丙酸)-OncoFAP |
| Bis-PEG4-acid-OncoFAP |
| Bis-PEG2-acid-OncoFAP |
6-((2,2-dimethyl-4-oxo-3,8,11-trioxa-5-azatridecan-13-yl)oxy)
quinoline-4-carboxylic acid
|
| H-PEG3-FAPI |
| 4-氨甲基-苯甲酸-D-Ala-boroPro |
| 4-氨基-苯甲酸-D-Ala-boroPro |
| H-PEG3(丙酸)-FAPI 46 |
| H-PEG4(丙酸)-FAPI 46 |
| H-PEG2(乙酸)-FAPI 46 |
| H-β-HoAsp-bis(PEG4-FAPI 46 |
| H-Asp-bis(PEG4-FAPI 46) |
| H-β-HoAsp-bis(PEG4-FAPI 04) |
| H-Asp-bis(PEG4-FAPI 04) |
| Bis-PEG3-acid-FAPI 46 |
| Bis-PEG2-acid-FAPI 46 |
| 4-(氟磺酰)氧基)苯甲酸-FAPI |
| 3-(氟磺酰)氧基)苯甲酸-FAPI |
| pent-4-yn-1-ol-FAPI |
| (S)-6-(2-(2-aminoethoxy)ethoxy)-N-(2-(2-cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)quinoline-4-carboxamide |
| (S)-6-(2-aminoethoxy)-N-(2-(2-cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)quinoline-4-carboxamide |
| (S)-6-(2-(2-(2-aminoethoxy)ethoxy)ethoxy)-N-(2-(2-cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)quinoline-4-carboxamide |
| NOTA-PEG2-FAPI |
| DOTA-PEG2-FAPI |
| UAMC1110-NH2 |
| H-Lys(Suc-FAPI)-巯基乙胺 |
| IPB-K(DOTA)-FAPI |
| IPB-DK(DOTA)-FAPI |
| HBED-CC-FAPI |
| CN-PEG4-FAPI |
| Omtriptolide-FAPI |
